Clinical Trials Browser

Phase 1/2 × iberdomide × 30 days × Clear all

NCT05583617 2026-06-03

PLYCOM

Phase 1/2 Recruiting

Multiple Myeloma

NCT05434689 2026-06-01

COMMANDER

Phase 1/2 Active not recruiting

Multiple Myeloma

NCT07601100 2026-06-01

IsaIberVD

Phase 1/2 Not yet recruiting

Multiple Myeloma